Reflux disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -Written informed consent. -Both male and female patients will be included. -Age above 18 years. -Symptoms of heartburn and/or acid regurgitation at least 3 times a week during the night. -A total reflux symptom score =8 (measured through the GERDQ questionnaire score).
Exclusion criteria
Exclusion criteria: -Nightshift workers -Surgery of the esophagus or stomach. -Regular use of sleep medication (benzodiazepines) that cannot be stopped during the duration of the trial. -Severe and clinically unstable concomitant disease (e.g. liver, cardiovascular or lung disease, neurological or psychiatric disorders, cancer or AIDS and other endocrine disorders). -Patients with obstructive sleep apnea.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment success, defined as a 50% reduction in Nocturnal GERD Symptom Severity score from baseline (N-GSSIQ questionnaire). | — |
Secondary
| Measure | Time frame |
|---|---|
| -Nocturnal reflux free nights (measured by symptom diary on daily basis – one question) -Change in reflux symptoms (measured by RDQ & symptom diary) -Change in nocturnal reflux symptoms (measured by N-GSSIQ questionnaire and symptom diary) -Change in work productivity (measured by WPAI-GERD questionnaire). -Change in sleep position during study (supine, prone, left lateral decubitus or right lateral decubitus). -Change in sleep quality (measured by the PSQI questionnaire) -Global assessment of treatment on nocturnal reflux symptoms (‘’ Compared to the start of the treatment, how would you rate your nocturnal reflux symptoms now?’’) | — |
Contacts
Amsterdam UMC (locatie AMC)